Ventricular tachycardia surgery: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Ventricular tachycardia}} {{CMG}} ==Surgery== According to few studies, patients with ventricular tachycardia may be preferred for surgery if the underlying caus...")
 
No edit summary
Line 5: Line 5:


==Surgery==
==Surgery==
According to few studies, patients with ventricular tachycardia may be preferred for surgery if the underlying cause is coronary heart disease and the condition:
According to few studies, patients with ventricular tachycardia may be preferred for surgery if the underlying cause is [[coronary heart disease]] and the patient:
* doesn't respond to antiarrhythmic drug therapy, or
* Does not respond to [[antiarrhythmic]] drug therapy
* has an underlying pathological condition of heart (tetralogy of fallot, aneurysm), or
* Has had a [[cardiac arrest]] in the past, and had monomorphic VT induced. This is especially desirable in patients who are already being considered for surgical revascularization.
* Has ventricular tachycardia and a disorder that is pathophysiologically related to the VT (such as postoperative [[tetralogy of fallot]])
 
Despite these ideas, revascularization alone has not been shown to prevent VT from recurring.
 
• Patients with VT resistant to antiarrhythmic drug therapy
        • Patients with a history of cardiac arrest in whom monomorphic VT is induced, especially if surgical revascularization is being considered
        • Patients with VT in whom aneurysm resection and/or mitral valve surgery is being considered to control ventricular dysfunction
        • Patients with VT and disorders associated with an identifiable pathophysiological substrate, such as postoperative tetralogy of Fallot
The ability to induce sustained monomorphic VT implies the presence of a fixed substrate; revascularization alone has not been shown to alter this substrate or prevent recurrent VT [13-15].
 





Revision as of 16:38, 25 October 2012


Ventricular tachycardia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Ventricular Tachycardia from other Disorders

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography

Cardiac MRI

Other Diagnostic Tests

Treatment

Medical Therapy

Electrical Cardioversion

Ablation

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ventricular tachycardia surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ventricular tachycardia surgery

CDC onVentricular tachycardia surgery

Ventricular tachycardia surgery in the news

Blogs on Ventricular tachycardia surgery

to Hospitals Treating Ventricular tachycardia surgery

Risk calculators and risk factors for Ventricular tachycardia surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Surgery

According to few studies, patients with ventricular tachycardia may be preferred for surgery if the underlying cause is coronary heart disease and the patient:

  • Does not respond to antiarrhythmic drug therapy
  • Has had a cardiac arrest in the past, and had monomorphic VT induced. This is especially desirable in patients who are already being considered for surgical revascularization.
  • Has ventricular tachycardia and a disorder that is pathophysiologically related to the VT (such as postoperative tetralogy of fallot)

Despite these ideas, revascularization alone has not been shown to prevent VT from recurring.

• Patients with VT resistant to antiarrhythmic drug therapy

       • Patients with a history of cardiac arrest in whom monomorphic VT is induced, especially if surgical revascularization is being considered
       • Patients with VT in whom aneurysm resection and/or mitral valve surgery is being considered to control ventricular dysfunction
       • Patients with VT and disorders associated with an identifiable pathophysiological substrate, such as postoperative tetralogy of Fallot

The ability to induce sustained monomorphic VT implies the presence of a fixed substrate; revascularization alone has not been shown to alter this substrate or prevent recurrent VT [13-15].


References